is...Long
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gregory Zivic, MD
@metacollectiveG
"Amplify Bio’s role is not understood by most. Combinations, expanding indications quickly requires expertise and business associations in an industry leading way beyond the clunkiness of current BP capability. Translation occurs when visionaries connect" $NWBO
#dcvax #allsolidtumors $nwbo #gbm https://t.co/9Vwv9eXqlr
— Peter Davis (@peter_brit) November 15, 2023
d_stock
@d_stock07734
"That was hilarious! The Australian pretentious hedgie blocked me right after I posted the figure and asked him whether he saw something like this. After all maybe he is not so pretentious".
#dcvax #allsolidtumors $nwbo #gbm https://t.co/bsmsKJCtct
— Peter Davis (@peter_brit) November 15, 2023
It’s my belief that FDA is deeply involved, and more poised to approve than anyone currently understands. The Real World Data that $NWBO has accumulated outside the trial correlates with recent guidances. As I’ve said a million times; I don’t believe in coincidence.
— Gregory Zivic, MD (@metacollectiveG) November 14, 2023
$NWBO A source has indicated that Ms. Posner eviscerated Citadel’s defense today. Should pave the way for the next steps in management’s PR schedule in my perspective. Perhaps KG’s Law Firm’s recent hire was more about offsetting loss than winning?
— Gregory Zivic, MD (@metacollectiveG) November 14, 2023
Delays perhaps, but the MTD will be thrown out one way or another. KG will fight it, yes, but over the coming weeks when the big $ follows the MAA submission and manufacturing reveals, combo trials, real world data release KG will be buying and legal shorts will get crushed.
— Gregory Zivic, MD (@metacollectiveG) November 14, 2023
Meditate on this statement and its implications. Lights out for most cancer treatments without strong real world evidence coming. The winners will be much fewer than you think. $NWBO DCVax being one of them. NIH/FDA/NCI building massive dataset for evaluating real world evidence. https://t.co/YQerOH902R
— Bio99 (@BIO99_BIO99) November 14, 2023
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) November 14, 2023
Laura Posner will deliver her oral arguments against 7 - rotten to the core - Market Makers.
The only thing that stands in the way of dismissal of MTD, will be corruption and a crooked judge.
Rest assured!!!
Chief of the New Jersey bureau of securities WILL prevail. pic.twitter.com/t5L9GE1pGq
#NWBO $NWBO #DCVAX If you know, you know... pic.twitter.com/vvwUJX5X5Q
— Adam Frankenstein (@AdamFranknstein) November 14, 2023
We are thrilled to now be welcoming the new @NIH Director at our Annual Meeting in one of her first interviews since being sworn in! The event is just one day away, and we anticipate seeing everyone in DC and virtually! #FriendsAM23
— Friends of Cancer Research (@CancerResrch) November 13, 2023
Register here: https://t.co/PDOsyR3Knu pic.twitter.com/lLiLeykHnG
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 14, 2023
So many long-term survival stories from Dr Liau's patients and $dcvax
Brian underwent surgery for his first of three brain tumors in December 2004 and sadly passed in 2016 and was in in the DCVax® trial.
He underwent surgery for his first… pic.twitter.com/qDfkZWCry2
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 14, 2023
Another excellent find by @HenryMuney
CTIM-15. T CELL RESPONSE DYNAMICS IN PHASE 3 GLIOBLASTOMA PATIENTS IMMUNIZED WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH AUTOLOGOUS TUMOR CELL LYSATE Get access Arrow
Marnix Bosch, Linda Liau, Keyoumars… https://t.co/tI8rlbmTdP
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 14, 2023
NWBO's July to September 2023 Findings Reveal Fascinating Results
Northwest Biotherapeutics Inc Reports Improved Financial Results, Surprising Investors
PUBLISHED NOV 12 2023 / MODIFIED NOV 13 2023
Source:
About CSIMarketOur mission…
Henry
@HenryMuney
$NWBO Patent issuance payment on November 1, 2023 🇧🇷 BR112018005180 - "Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers"
The date format is day/month/year in the screenshot. Next step, grant.
#dcvax #allsolidtumors $nwbo #gbm https://t.co/MuMOTe5pv3
— Peter Davis (@peter_brit) November 14, 2023
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) November 13, 2023
Here are some of the challenges that a competitor would face in replicating NWBOs manufacturing process: pic.twitter.com/s42tTZmbnR
Cytokine storm, the often lethal side effect of many immunotherapies (except for $NWBO DCVax)… yet another game changer in the analysis of DCVax and its approval and combo potential… https://t.co/2O9UqAX7L0
— Bio99 (@BIO99_BIO99) November 13, 2023
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 13, 2023
Collaborating for change at the NICE conference 2023
We recently attended the NICE 2023 conference and share some of the key takeaways we gathered from the event.
Thursday 9 November 2023
"Throughout our day at the NICE conference 2023 we…
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 13, 2023
Cell culture is at the cutting edge of biological innovation. However, the need to reach commercial scale presents many practical, scientific, regulatory, and ideological challenges.
Scalability is the biggest challenge
For cellular products…
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 13, 2023
Revolutionizing Proteomics: Unlocking the potential of automation to overcome industry bottlenecks
: Oct 27, 2023
"Proteomics is the area of research that studies protein expression, interactions, function, structure, and post-translational… pic.twitter.com/OQpWWWqobX
Dr. Thomas Ichim
@exosome
It is important to think about NK cells when developing #cancer #immunotherapy like $nwbo
#dcvax #allsolidtumors $nwbo #gbm https://t.co/g525FuYI0w
— Peter Davis (@peter_brit) November 13, 2023
Based on the low revenues listed in last week’s $NWBO 10Q and the fact that we know from many different sources that Advent has been running at greater than maximum capacity (hundreds of patients per month potentially) to produce DCVax for compassionate treatment since May, the…
— Bio99 (@BIO99_BIO99) November 12, 2023
$NWBO This week should be very interesting. Once the dam is opened the torrents will run wild across the market. Watching the buy action during the past 2 weeks it appears obvious… https://t.co/DN3noc2JrJ
— Gregory Zivic, MD (@metacollectiveG) November 12, 2023
$NWBO Introducing DCVax ®: a revolutionary approach to empower your body’s own defenses against cancer. It’s not just a treatment; it’s an intelligent design to recalibrate your immune system, making it smarter, more responsive. This is innovation at the intersection of… https://t.co/Hd1fGqdwtc
— Andrew Caravello, DO (@andrewcaravello) November 12, 2023
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 12, 2023
And with the newly confirmed DCVax® Trademark update November 10, 2023 comes this impressive list stated as 'Goods or Services'
Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention,… pic.twitter.com/lYOKGn9xiS
GHK is watching closely and also mentioned the NHS King's College Hospital interview with Prof Keyoumars Ashkan.https://t.co/Edtry6xnrT #DCVax-L $NWBO pic.twitter.com/BLxH4ve6p6
— Henry (@HenryMuney) November 12, 2023
rj
@sharpie510
"I think they renewed the trademark and submitted a new image for it. Seems like they plan on keeping the #DCVax® name. Murcidencel is the generic name they were assigned but it sounds like DCVax® is going to remain the platform name". $NWBO
The update is in USPTO DOCUMENTS tab.
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 12, 2023
Thanks @sharpie510
rj@sharpie510
DCVax® Trademark update November 10, 2023.
Thanks for the confirmation of this only created on the system Nov 10 https://t.co/Jt5KZAtk9t pic.twitter.com/az2qEwb7FT
I think they renewed the trademark and submitted a new image for it. Seems like they plan on keeping the #DCVax® name. Murcidencel is the generic name they were assigned but it sounds like DCVax® is going to remain the platform name. $NWBO
— rj (@sharpie510) November 11, 2023
The update is in USPTO DOCUMENTS tab.
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 12, 2023
Life-saving drug trials to get go-ahead faster under Brexit plans to cut red tape
Steve Barclay, the Health Secretary, to announce new fast-track process halving time it takes for some research to get under way
11 November 2023 •…
#dcvax #allsolidtumors #nwbo #gbm
— Peter Davis (@peter_brit) November 11, 2023
Looking into the UK's new 'The Innovative Devices Access Pathway (IDAP) pilot' I believe @BIO99_BIO99 has identified an excellent option for $nwbo to take advantage of.
The Innovative Devices Access Pathway (IDAP) pilot is an initiative to… pic.twitter.com/rSXbgiHLuo
I had not seen this one...
Another one... $NWBO 🎼🙌👍 https://t.co/vh3soM4c7e
— Erik Garcia G. (@BistroBoys) November 11, 2023
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 11, 2023
NEWS
10 November 2023
AI that reads brain scans shows promise for finding Alzheimer’s genes
Machine-learning approach detects Alzheimer’s disease with an accuracy of more than 90% — a potential boon for clinicians and scientists developing…
Russia will never defeat these amazing Ukrainians. Never. https://t.co/xA1onHWVrK
— Michael McFaul (@McFaul) November 10, 2023
$NWBO FYI pic.twitter.com/iNBemKButM
— StonkMaster (@StonkMasterJ) November 10, 2023
Activated T cells expressing CD40 ligand can stimulate dendritic cells to make IL-12....we always think of how dendritic cells activate T cells...but seldom of how T cells activated DC
— Dr. Thomas Ichim (@exosome) November 10, 2023
great stuff for ways of augmenting $NWBO approacheshttps://t.co/IiVQegkYHl
Curious. $NWBO. IDAP pilot. From the UK govt website: "Criterion 4: Enabling early diagnosis and treatments, including immune therapies such as cancer vaccines.". Announcements of selected devices to be made in December... Eden??? One wonders.https://t.co/SyIHlILJOw
— Bio99 (@BIO99_BIO99) November 10, 2023
Yesterday's announcement of Phase II failure of Atara Biotherapeutics ($ATRA)' allogeneic T-cell vaccine, ATA188, underscores the challenges of such therapies. Autologous dendritic cell vaccines like $NWBO DCVax offer a more personalized, effective approach, aligning with…
— Bio99 (@BIO99_BIO99) November 10, 2023
#dcvax #allsolidtumors $nwbo #gbm https://t.co/FYeOvihsnP
— Peter Davis (@peter_brit) November 10, 2023
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 10, 2023
Never tire of watching this....https://t.co/x7qEn7dspl
What a week we have ahead of us..
Monday 13th November:
We are in the window to expect the following:-
"The Company anticipates that the remaining section of the MAA package will be delivered to the publisher within about two weeks after the consultants return"
In precisely two weeks, on November 14th, oral arguments are scheduled in $NWBO litigation concerning market manipulation, specifically addressing issues like spoofing and potentially mentioning naked shorting by market makers. I am very curious as to what critical information…
— Bio99 (@BIO99_BIO99) October 31, 2023
#dcvax #allsolidtumors $nwbo #gbm https://t.co/eBpBfD9KMm pic.twitter.com/ihpwvvDsTf
— Peter Davis (@peter_brit) October 17, 2023
Stay up to date on the latest practice-changing advancements in #Glioblastoma management with experts @StevenBremMD @BrainTumorDoc @MichelleMKimMD! Join PeerView & @theABTA on Thursday, November 16th at 5:15 PM PST during #SNO2023! https://t.co/8PTUiXsCC1 #BTSM #BrainTumor #MedEd pic.twitter.com/oUCdlJFpGM
— PeerView (@PeerView) November 7, 2023
#dcvax #allsolidtumors $nwbo #gbm https://t.co/9HbLoC63sH pic.twitter.com/PrXwF81zxb
— Peter Davis (@peter_brit) November 8, 2023